Perspective Therapeutics
CATX • AMEX
Perspective Therapeutics is a medical - devices company in the healthcare sector trading on AMEX, led by CEO Johan Spoor, with a market cap of $463.7M.
CEOJohan Spoor
Next Earnings
Upcoming earnings announcement for Perspective Therapeutics
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.30
Revenue Estimate
$214.3K
Earnings History
Past 12 earnings reports for Perspective Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Q4 2025 | -$0.51Est: -$0.35 | -45.7% | $43.0KEst: $254.2K | -83.1% |  10-K |
| Nov 10, 2025 | Q3 2025 | -$0.35Est: -$0.32 | -9.4% | $209.0KEst: $244.1K | -14.4% | 10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.30Est: -$0.29 | -3.4% | $290.0KEst: $242.2K | +19.7% | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.25Est: -$0.27 | +7.4% | $342.0KEst: $143.9K | +137.6% | 10-Q |
| Mar 26, 2025 | Q4 2024 | -$0.60Est: -$0.26 | -130.8% | $234.0KEst: $302.5K | -22.6% | 10-K/A |
| Nov 12, 2024 | Q3 2024 | -$0.21Est: -$0.21 | 0.0% | $369.0KEst: $170.0K | +117.1% | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.17Est: -$0.21 | +19.0% | $526.0KEst: $60.0K | +776.7% | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.20Est: -$0.20 | 0.0% | $325.0K | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.90 | — | $2.0M | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.40Est: -$0.40 | 0.0% | $2.2MEst: $2.2M | -1.6% | — |
| Aug 11, 2023 | Q2 2023 | -$0.40Est: -$0.30 | -33.3% | $2.1MEst: $2.6M | -20.0% | — |
| May 15, 2023 | Q1 2023 | $0.00Est: -$0.10 | +100.0% | $2.1MEst: $4.3M | -52.0% | — |